Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on February 17, 2026

3 hours ago

BostonSight Unveils 5-Year Roadmap to Advance Scleral Lens Technology, Research, and Education

EIN Presswire

28 minutes ago

BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

GlobeNewswire

28 minutes ago

Outlook Therapeutics Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update

GlobeNewswire

28 minutes ago

Cellectar Biosciences Expands Global Intellectual Property Estate

GlobeNewswire

33 minutes ago

Nasus Pharma to Present Data Highlighting Superior Nasal Deposition and Stability of Intranasal Epinephrine Powder at AAAAI 2026

GlobeNewswire

33 minutes ago

Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026

GlobeNewswire

33 minutes ago

Casey House releases Big Fucking Deal, a short film examining the compounding effects of stigma for people living with HIV

GlobeNewswire

33 minutes ago

Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases

GlobeNewswire

33 minutes ago

Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy

GlobeNewswire

33 minutes ago

MediWound to Present at Upcoming Investor Conferences

GlobeNewswire

33 minutes ago

Aprea Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

GlobeNewswire

33 minutes ago

Extendicare Announces February 2026 Dividend of C$0.042 per Share

GlobeNewswire

33 minutes ago

Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026

GlobeNewswire

33 minutes ago

Fulcrum Therapeutics to Present 12-Week Data from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

GlobeNewswire

33 minutes ago

Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040

GlobeNewswire

33 minutes ago

MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25

GlobeNewswire

33 minutes ago

Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

33 minutes ago

Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

33 minutes ago

Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference

GlobeNewswire

33 minutes ago

Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers

GlobeNewswire